Abraham H. Hulst, Jeroen Hermanides, Mark L. van Zuylen
<p>We read with interest the study by Nersessian et al., which explores the relationship between peri-operative semaglutide use and increased residual gastric content as assessed by gastric ultrasound [<span>1</span>]. This prospective study contributes to the emerging literature on GLP-1 receptor agonists (GLP-1 RAs) and delayed gastric emptying, raising important considerations for peri-operative management [<span>2</span>]. However, these findings prompt a need for greater specificity within clinical guidelines, particularly regarding the differing needs of patients using GLP-1 RAs for weight loss and to those prescribed these drugs for type 2 diabetes.</p>